Clinical Trial Update: Prednisolone for 12 Versus 6 Months to Treat Pulmonary Sarcoidosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing 12 months versus 6 months of prednisolone for pulmonary sarcoidosis; recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Sarcoidosis | Phase 4 | Status: NOT_YET_RECRUITING